Trilobatin rescues cognitive impairment of Alzheimer’s disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway

Qihai Gong(Zunyi Medical University)
Acta Pharmacologica Sinica
March 15, 2022
Cited by 83


Related Papers